MX2013006846A - Inhibidores de la replicacion de los virus de la influenza. - Google Patents

Inhibidores de la replicacion de los virus de la influenza.

Info

Publication number
MX2013006846A
MX2013006846A MX2013006846A MX2013006846A MX2013006846A MX 2013006846 A MX2013006846 A MX 2013006846A MX 2013006846 A MX2013006846 A MX 2013006846A MX 2013006846 A MX2013006846 A MX 2013006846A MX 2013006846 A MX2013006846 A MX 2013006846A
Authority
MX
Mexico
Prior art keywords
patient
influenza viruses
pharmaceutically acceptable
structural formula
biological sample
Prior art date
Application number
MX2013006846A
Other languages
English (en)
Inventor
Huai Gao
Emanuele Perola
Paul S Charifson
Michael P Clark
Joseph M Kennedy
Mark W Ledeboer
Ioana Davies
Francois Maltais
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of MX2013006846A publication Critical patent/MX2013006846A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invención describe métodos para inhibir la replicación de los virus de la influenza en una muestra biológica o paciente, para reducir la cantidad de los virus de la influenza en una muestra biológica o paciente y para tratar la influenza en un paciente que comprenden la etapa de administrar a la muestra biológica o paciente una cantidad eficaz de un compuesto representado por la Fórmula estructural (I): (Ver Formula) o una sal farmacéuticamente aceptable de estos, en donde los valores de la Fórmula estructural (I) son tal como se describieron en la presente descripción. Un compuesto está representado por la Fórmula estructural (I) o una sal farmacéuticamente aceptable de esta, en donde los valores de la Fórmula estructural (I) son tal como se describieron en la presente descripción. Una composición farmacéutica comprende una cantidad eficaz del compuesto o sal farmacéuticamente aceptable de este y un portador, adyuvante o vehículo farmacéuticamente aceptable.
MX2013006846A 2010-12-16 2011-12-16 Inhibidores de la replicacion de los virus de la influenza. MX2013006846A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42392510P 2010-12-16 2010-12-16
US201161527276P 2011-08-25 2011-08-25
PCT/US2011/065388 WO2012083121A1 (en) 2010-12-16 2011-12-16 Inhibitors of influenza viruses replication

Publications (1)

Publication Number Publication Date
MX2013006846A true MX2013006846A (es) 2013-12-16

Family

ID=45478532

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013006846A MX2013006846A (es) 2010-12-16 2011-12-16 Inhibidores de la replicacion de los virus de la influenza.

Country Status (10)

Country Link
US (1) US20140005197A1 (es)
EP (1) EP2651941A1 (es)
JP (1) JP2013545817A (es)
KR (1) KR20130128436A (es)
CN (1) CN103492382A (es)
AU (1) AU2011343646A1 (es)
CA (1) CA2822059A1 (es)
MX (1) MX2013006846A (es)
RU (1) RU2013132717A (es)
WO (1) WO2012083121A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3141252B8 (en) 2009-06-17 2019-03-13 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
RU2013132681A (ru) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP3578554A1 (en) 2013-11-13 2019-12-11 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
KR102338461B1 (ko) 2013-11-13 2021-12-13 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제 억제제의 제조 방법
EP3294735B8 (en) 2015-05-13 2022-01-05 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
WO2016183116A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
WO2017097234A1 (en) 2015-12-09 2017-06-15 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
CA3011894A1 (en) 2016-01-31 2017-08-03 University Of Massachusetts Branched oligonucleotides
WO2017133665A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh 6,7-diazaindazole and 6,7-diazaindole derivatives and use in treatment, amelioration or prevention of influenza thereof
WO2017133670A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza
WO2017133667A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyrimidine and pyridine derivatives and use in treatment, amelioration or prevention of influenza thereof
WO2017133658A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh 4, 7-diazaindole and 4, 7-diazaindazole derivatives and their use in the treatment, amelioration or prevention of influenza
WO2017133664A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Bicyclic pyridine and pyrimidine derivatives and their use in the treatment， amelioration or prevention of influenza
WO2017133657A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza
WO2018033082A1 (en) 2016-08-16 2018-02-22 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
CN109641868B (zh) * 2016-08-30 2021-12-03 广东东阳光药业有限公司 流感病毒复制抑制剂及其使用方法和用途
WO2018108125A1 (en) 2016-12-15 2018-06-21 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
WO2018127096A1 (en) * 2017-01-05 2018-07-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CN110446711B (zh) 2017-03-02 2022-02-15 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
CN108727369B (zh) * 2017-04-25 2023-06-09 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
WO2019089734A1 (en) * 2017-10-31 2019-05-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and compositions for the treatment of influenza
WO2020198509A2 (en) 2019-03-26 2020-10-01 University Of Massachusetts Modified oligonucleotides with increased stability
CN110787170B (zh) * 2019-12-19 2022-06-28 浙江立恩生物科技有限公司 一种治疗流感病毒感染的药物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2420210A1 (en) 2000-09-22 2002-03-28 Michael Edward Kobierski Stereoselective process for preparing cyclohexyl amine derivatives
WO2002102800A1 (en) * 2001-06-15 2002-12-27 Vertex Pharmaceuticals Incorporated 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
JP4370164B2 (ja) 2001-08-14 2009-11-25 富山化学工業株式会社 新規なウイルス増殖阻害・殺ウイルス方法および新規なピラジンヌクレオチド・ピラジンヌクレオシド類似体
TWI372624B (en) 2004-03-30 2012-09-21 Vertex Pharma Azaindoles useful as inhibitors of jak and other protein kinases
SI2332940T1 (sl) * 2004-03-30 2013-03-29 Vertex Pharmaceuticals Incorporated Azaindoli, uporabni kot inhibitorji jak in drugih protein-kinaz
US7855205B2 (en) * 2004-10-29 2010-12-21 Janssen Pharmaceutica Nv Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
MX2007014327A (es) * 2005-05-16 2008-02-11 Irm Llc Derivados de pirrolopiridina como inhibidores de cinasa de proteina.
BRPI0722364A2 (pt) 2006-01-17 2011-08-16 Vertex Pharma azaindóis, composição farmacêutica e usos dos referidos compostos
EP2215089B1 (en) 2007-11-02 2012-06-27 Vertex Pharmaceuticals Incorporated [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
EP2318408B1 (en) 2008-07-23 2016-02-17 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
JP2011529062A (ja) 2008-07-23 2011-12-01 バーテックス ファーマシューティカルズ インコーポレイテッド ピラゾロピリジンキナーゼ阻害剤
JP5631310B2 (ja) 2008-07-23 2014-11-26 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 三環式ピラゾロピリジンキナーゼ阻害剤
US20100038988A1 (en) 2008-08-12 2010-02-18 Gannon Ramy Stator and Method of Making the Same
EP3141252B8 (en) * 2009-06-17 2019-03-13 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication

Also Published As

Publication number Publication date
AU2011343646A1 (en) 2013-05-02
US20140005197A1 (en) 2014-01-02
RU2013132717A (ru) 2015-01-27
KR20130128436A (ko) 2013-11-26
JP2013545817A (ja) 2013-12-26
WO2012083121A1 (en) 2012-06-21
CN103492382A (zh) 2014-01-01
EP2651941A1 (en) 2013-10-23
CA2822059A1 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
PH12015501678A1 (en) Inhibitors of influenza viruses replication
MX2013006846A (es) Inhibidores de la replicacion de los virus de la influenza.
MX2014001067A (es) Inhibidores de replicacion del virus de influenza.
WO2012083122A8 (en) Inhibitors of influenza viruses replication
MD4602B1 (ro) Inhibitori ai virusului hepatic C
MX2012015097A (es) Derivados de acido naft-2-ilacetico para tratar sida.
UA114907C2 (uk) Гетероциклільні сполуки як інгібітори mek
PH12014501134B1 (en) 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
MX2009008439A (es) Nuevos inhibidores de la replicacion del virus de hepatitis c.
EA201590453A1 (ru) Конденсированные бициклические производные сульфамоила и их применение в качестве лекарственных препаратов для лечения гепатита b
UY32062A (es) Inhibidores de beta-secretasa
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
MY183588A (en) New salvianolic acid compound l, preparation method and use thereof
EA201391098A1 (ru) C-28-амины c-3-модифицированных производных бетулиновой кислоты в качестве ингибиторов созревания вич
MX350746B (es) Derivados de ciclosporina novedosos para el tratamiento y la prevención de una infección viral.
MX2012014918A (es) Compuestos y metodos para tratamiento o prevencion de infecciones por flavivirus.
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
PH12019502376A1 (en) Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
GEP20166481B (en) (crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors
MY173491A (en) Therapeutic or prophylactic agent for biliary tract diseases
TN2014000031A1 (en) Use of organic compound for the treatment of noonan syndrome
EA201691083A1 (ru) Ингибиторы репликации вирусов гриппа
UA58748U (ru) Способ лечения рецидивирующей герпетической инфекции
TN2013000335A1 (en) Hepatitis c virus inhibitors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal